Discover 489 paid clinical trials in Providence, Rhode Island. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 489
Active & Responsive
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
for
Alzheimer's Disease
Location: East Providence RI, Newton MA, New York NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 60 - 70+
Code: NCT06976216
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waterbury CT,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT07231419
Phase 3, Recruiting
Active & Responsive
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
for
Diabetic Peripheral Neuropathic Pain
Location: East Greenwich RI, Boston MA, Waltham MA, New York NY,
Sponsor: Vertex Pharmaceuticals Incorporated
Sex: All
Age: 18 - 70+
Code: NCT06628908
Phase 3, Recruiting
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
for
Obesity, Overweight
Location: East Greenwich RI, Waterbury CT, Binghamton NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684235
Phase 3, Recruiting
Active & Responsive
A Study of V132 in Healthy Older Participants (V132-001)
for
Healthy
Location: East Greenwich RI, Columbus OH, Hollywood FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 50 - 70+
Code: NCT07712575
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
for
Obesity, Overweight, Diabetes Mellitus, Type 2
Location: East Greenwich RI, Trenton NJ, Annapolis MD, Burke VA,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07684144
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
for
Menstrual Migraine
Location: East Greenwich RI, The Bronx NY, Philadelphia PA,
Sponsor: Pfizer
Sex: Female
Age: 18 - 45
Code: NCT06641466
Phase 3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for
Migraine
Location: Providence RI, Fall River MA, Foxborough MA,
Sponsor: TriGemX Bio, Inc.
Sex: All
Age: 18 - 70+
Code: NCT07816367
Phase 3, Recruiting
Active & Responsive
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer